Clinical trial
Modeling Genotype and Other Factors to Enhance the Safety of Coumadin…
NCT00484640 · Agency for Healthcare Research and Quality (AHRQ), U.S. Fed · Unknown status
Key facts
| NCT number | NCT00484640 |
|---|---|
| Title | Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing |
| Official title | Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing |
| Lead sponsor | Agency for Healthcare Research and Quality (AHRQ), U.S. Fed |
| Collaborators | Marshfield Clinic Research Foundation |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Atrial Fibrillation, Deep Venous Thrombosis, Heart Valve Replacement, Pulmonary Embolism |
| Intervention type | Drug |
| Interventions | Coumadin |
| Enrollment | 260 |
| Start date | Jun 1, 2007 |
| Completion | May 1, 2008 |
| First posted | Jun 11, 2007 |
| Last update posted | Jun 11, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: